Hesperidin significantly reduces HDAC3 activity at the catalytic tyrosine 298 residue and, simultaneously, markedly inhibits HDAC3 expression by suppressing NFκBp65/CEBPβ signaling, thereby impeding the metastatic spread of GC cells.234. The gene discussed is HDAC3; the disease is gastric cancer.